MENU
+Compare
ALVO
Stock ticker: NASDAQ
AS OF
Aug 12, 04:59 PM (EDT)
Price
$8.64
Change
+$0.13 (+1.53%)
Capitalization
2.67B

ALVO Alvotech Forecast, Technical & Fundamental Analysis

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALVO with price predictions
Aug 11, 2025

ALVO in +0.89% Uptrend, advancing for three consecutive days on August 11, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ALVO advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALVO's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALVO as a result. In of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALVO turned negative on August 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ALVO moved below its 50-day moving average on July 30, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALVO broke above its upper Bollinger Band on July 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALVO entered a downward trend on July 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (20.163). P/E Ratio (23.014) is within average values for comparable stocks, (71.882). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.441). ALVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (4.141) is also within normal values, averaging (40.856).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALVO is expected to report earnings to fall 100.66% to 0 cents per share on August 13

Alvotech ALVO Stock Earnings Reports
Q2'25
Est.
$0.00
Q1'25
Beat
by $0.32
Q4'24
Missed
by $0.15
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.59
The last earnings report on May 07 showed earnings per share of 34 cents, beating the estimate of 2 cents. With 112.93K shares outstanding, the current market capitalization sits at 2.67B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSUAX24.39N/A
N/A
Cohen & Steers Global Infrastructure A
ATGAX38.96N/A
N/A
Cantor Fitzgerald Equity Opp A
FTWRX18.74N/A
N/A
Templeton World R6
OSTGX16.27N/A
N/A
Osterweis Opportunity Fund
MGIAX43.55-0.18
-0.41%
MFS International Intrinsic Value A

ALVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+0.65%
EBS - ALVO
28%
Poorly correlated
-0.97%
KMDA - ALVO
22%
Poorly correlated
+3.09%
ACB - ALVO
22%
Poorly correlated
+16.52%
PBH - ALVO
21%
Poorly correlated
-2.58%
CRON - ALVO
21%
Poorly correlated
+16.09%
More

Groups containing ALVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+0.65%
Pharmaceuticals: Generic
industry (227 stocks)
11%
Poorly correlated
+0.48%